Malvern, PA, United States of America

James Patrick Tursi

This inventor holds 1 USPTO granted patent. Top assignee: Endo Global Aesthetics Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James Patrick Tursi. Retrieved from https://idiyas.com/inventor/james-patrick-tursi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: James Patrick Tursi and His Patent on Reducing Cellulite-Related Bruising.

Introduction

James Patrick Tursi is an inventor associated with Malvern, Pennsylvania, and Endo Global Aesthetics Limited. His patent work addresses a treatment-related concern in aesthetic medicine: reducing bruising associated with cellulite.

Latest Patents

Tursi is credited with 1 patent: “Methods of Reducing Collagenase-Mediated Bruising in a Subject Having Cellulite.” The patent describes methods intended to reduce bruising mediated by collagenase in a subject with cellulite.

Career Highlights

Tursi’s listed invention focuses on an issue relevant to cellulite treatment and aesthetic care. His patent record connects his work with Endo Global Aesthetics Limited.

Collaborations

Saji Vijayan and David Hernandez are identified as Tursi’s coworkers. Their shared association with the company provides context for his professional environment, though the supplied information does not specify their roles in the patent.

Conclusion

James Patrick Tursi’s patent highlights an effort to address collagenase-mediated bruising in people with cellulite, reflecting an innovation focused on treatment-related outcomes in aesthetic medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…